Skip to main content
. 2022 Mar 18;10:817180. doi: 10.3389/fcell.2022.817180

FIGURE 1.

FIGURE 1

Schematic representation of experimental animal models obtained for a period of 4 months. Golden Syrian hamsters (67 males and 3 months old) were divided into seven experimental groups: (1) control (C group); (2) simultaneously hypertensive–hyperlipidemic (HH group); (3,4) HH hamsters with retro-orbital sinus injection containing 100 μg/ml EVs from both ADSCs and BM-MSCs (HH-EVs (ADSCs) group and HH-EVs (MSCs) group)); (5,6) HH hamsters with retro-orbital sinus injection containing 100 μg/ml EVs (from ADSCs or BM-MSCs) transfected with 100 nM Smad2/3 siRNA (HH-EVs (ADSCs)+Smad2/3 siRNA group and HH-EVs (MSCs)+ Smad2/3 siRNA group); (7) HH hamsters with subcutaneous injection containing 100 nM Smad2/3 siRNA (HH-Smad2/3 siRNA group). The HH group was obtained by combining the atherogenic and high-salt diet.